Inhibition of CHK1 enhances cell death induced by the Bcl-2-selective inhibitor ABT-199 in acute myeloid leukemia cells

Resistance to standard chemotherapy agents remains a major obstacle for improving treatment outcomes for acute myeloid leukemia (AML). The Bcl-2-selective inhibitor ABT-199 has demonstrated encouraging preclinical results, drug resistance remains a concern. Mcl-1 has been demonstrated to contribute...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Jianyun, Niu, Xiaojia, Li, Xinyu, Edwards, Holly, Wang, Guan, Wang, Yue, Taub, Jeffrey W, Lin, Hai, Ge, Yubin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085189/
https://www.ncbi.nlm.nih.gov/pubmed/27166183
http://dx.doi.org/10.18632/oncotarget.9185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085189/
https://www.ncbi.nlm.nih.gov/pubmed/27166183
http://dx.doi.org/10.18632/oncotarget.9185

Ejemplares similares